Perform Another (Advanced) Search

1.  CenterWatch: Clinical Trials in Category (74) Glaucoma
...CenterWatch: Clinical Trials in Category (74) Glaucoma Glaucoma State • California • Pennsylvania California Cypress : West Coast Clinical Trials Open Angle Glaucoma Study Pennsylvania Philadelphia ...
View Page

2.  CenterWatch: New Medical Therapies in Disease Category (74), Glaucoma
...CenterWatch: New Medical Therapies in Disease Category (74), Glaucoma Glaucoma Patient Medical Areas • Ophthalmology May 12, 2008 Pfizer and NicOx reported mixed results from a ...
View Page

3.  Study Posting (1386) Trial #157005, Glaucoma, Cypress, CA
...Study Posting (1386) Trial #157005, Glaucoma, Cypress, CA Trial Information Open Angle Glaucoma Study May receive compensation up to $2,550 Have you been diagnosed with glaucoma? Are ...
View Page

4.  Study Posting (3736) Trial #154994, Glaucoma, Philadelphia, PA
...Study Posting (3736) Trial #154994, Glaucoma, Philadelphia, PA Trial Information Do you have Glaucoma or Ocular Hypertension? This is a study of the Latanoprost Punctal Plug Delivery System in ...
View Page

5.  Study Posting (3736) Trial #154996, Glaucoma, Philadelphia, PA
...Study Posting (3736) Trial #154996, Glaucoma, Philadelphia, PA Trial Information Do you have Glaucoma or Ocular Hypertension? This a study of the effects of Artificial Tears Preserved with Benzalkonium ...
View Page

6.  Study Posting (3736) Trial #153663, Glaucoma, Philadelphia, PA
...Study Posting (3736) Trial #153663, Glaucoma, Philadelphia, PA Trial Information Are you using Istalol or Betimol? A 1 day study (survey) on patients with open angle glaucoma or ocular hypertension Patient Inclusion Criteria: • 21 years of age or older • Diagnosis of open ...
View Page

7.  Study Posting (3736) Trial #154995, Ocular Hypertension, Philadelphia, PA
...Study Posting (3736) Trial #154995, Ocular Hypertension, Philadelphia, PA Trial Information Do you have Glaucoma or Ocular Hypertension? This is a study of the Latanoprost Punctal Plug Delivery System in subjects with Ocular Hypertension or Open Angle Glaucoma Inclusion Criteria • 18 years of age or older • Best corrective visual acuity of 20/100 ...
View Page

8.  Study Posting (3736) Trial #154997, Ocular Hypertension, Philadelphia, PA
...Study Posting (3736) Trial #154997, Ocular Hypertension, Philadelphia, PA Trial Information Do you have Glaucoma or Ocular Hypertension? This a study of the effects of Artificial Tears Preserved with Benzalkonium ...
...to the Latanoprost Punctal Plug Delivery System in subjects with Ocular Hypertension or Open Angle Glaucoma Inclusion Criteria • 18 years of age or older • Best corrective visual acuity of 20/100 ...
View Page

9.  Newly Approved Drug Therapies (601) Betaxon, Alcon,
...February 2000 Treatment Area: For lowering intraocular pressure (IOP) in patients with chronic open-angle glaucoma or ocular hypertension General Information Betaxon (levobetaxolol hydrochloride suspension, drops) is an ophthalmic suspension which ...
...nerve damage and visual field loss. Most of the diseases of the eye which cause glaucoma are characterized by increased IOP. Currently, there is no cure for glaucoma. Furthermore, since there ...
View Page

10.  Newly Approved Drug Therapies (690) Travatan (travoprost ophthalmic solution), Alcon,
...Drug Name: Travatan (travoprost ophthalmic solution) Company: Alcon Approval Status: Approved March 2001 Treatment Area: Glaucoma or ocular hypertension General Information Travatan has been approved by the FDA for the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension. It is indicated for patients who are intolerant of or insufficiently responsive ...
View Page

11.  Study Posting (3736) Trial #153664, Ocular Hypertension, Philadelphia, PA
...you using Istalol or Betimol? A 1 day study (survey) on patients with open angle glaucoma or ocular hypertension Patient Inclusion Criteria: • 21 years of age or older • Diagnosis of open angle glaucoma or ocular hypertension in at least 1 eye • Currently being treated with Istalol or Betimol ...
View Page

12.  CenterWatch: Clinical Trials in Category (202) Ocular Hypertension
...Eye Associates Are you using Istalol or Betimol? Philadelphia : Philadelphia Eye Associates Do you have Glaucoma or Ocular Hypertension? Philadelphia : Philadelphia Eye Associates Do you have Glaucoma or Ocular Hypertension? Tennessee Clarksville : Alpha Clinical Research, LLC Are you currently using Xalatan Eye ...
View Page

13.  Newly Approved Drug Therapies (689) Lumigan (bimatoprost ophthalmic solution), Allergan,
...Drug Name: Lumigan (bimatoprost ophthalmic solution) Company: Allergan Approval Status: Approved March 2001 Treatment Area: Glaucoma or ocular hypertension General Information Lumigan has been approved by the FDA for the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension who are intolerant of or insufficiently responsive to other IOP-lowering medications ...
View Page

14.  Newly Approved Drug Therapies (166) Alphagan (brimonidine), Allergan,
...Drug Name: Alphagan (brimonidine) Company: Allergan Approval Status: Approved September 1996 Treatment Area: open-angle glaucoma and ocular hypertension General Information Alphagan has been approved for the treatment of open-angle glaucoma and ocular hypertension. Mechanism of Action Alphagan is a selective alpha-2 agonist, which significantly ...
View Page

15.  CenterWatch: Patient Resources for Otolaryngology
...Site An educational web-site pertaining to the inner ear, dizziness and other related illnesses. Glaucoma Foundation Information to help you and your loved ones avoid the tragedy of blindness. Glaucoma Research Foundation Information and resources on GRF programs, glaucoma and glaucoma-related issues. Handspeak A ...
View Page

16.  Newly Approved Drug Therapies (638) Rescula (unoprostone isopropyl ophthalmic solution) 0.15%, Ciba Vision,
...August 2000 Treatment Area: For the lowering of intraocular pressure in patients with open-angle glaucoma or ocular hypertension General Information Rescula is a docosanoid compound recently approved by the FDA for treatment of open-angle glaucoma or ocular hypertension. It is used for the lowering of intraocular pressure in patients who ...
View Page

17.  Newly Approved Drug Therapies (429) Cosopt, Merck,
...medical conference presentations. Drug Name: Cosopt Company: Merck Approval Status: Approved April 1998 Treatment Area: glaucoma or ocular hypertension General Information Cosopt has been approved for the reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension who do not respond adequately to beta-blockers alone. Both components of ...
View Page

18.  CenterWatch New Medical Therapies™ in Ophthalmology
...Cataracts Conjunctivitis, Bacterial Diabetic Macular Edema Diabetic Retinopathy Eye Disorders/Infections Eye Disorders/Infections (Pediatric) Glaucoma Leber's Hereditary Optic Neuropathy (LHON) Macular Degeneration Macular Edema Ocular Hypertension Posterior Uveitis Retinitis ...
View Page

19.  CenterWatch: Clincial Trial Listings in Ophthalmology
...Bacterial   (8, 2 New! ) Diabetic Macular Edema   (63) Diabetic Retinopathy   (62) Eye Disorders/Infections   (41) Glaucoma   (4) Macular Edema   (62) Ocular Hypertension   (4) Retinoblastoma   (1) Sjogren's Syndrome   (1) Jobson Medical ...
View Page

20.  CenterWatch: New Medical Therapies in Disease Category (202), Ocular Hypertension
...marketing study investigating Lumigan (bimatoprost ophthalmic solution), a synthetic prostamide analog for the treatment of glaucoma. Results showed that the average reduction in eye pressure was greater for subjects treated with ...
...with both medications. The randomized, blinded study enrolled 269 subjects with ocular hypertension and/or glaucoma. Jobson Medical Information • Privacy | • Glossary Copyright © 1995-2010 Jobson Medical Information LLC. Designed by Piehead ...
View Page